TABLE 4.
Bivariate analysis of factors influencing the risk of postoperative medical complications
Factor | OR (95% CI) | p Value |
---|---|---|
Comorbidity | ||
Cardiovascular disease | 11.8 (4.5–31.1) | <0.001 |
Gastrointestinal disease | NA | — |
Congenital or genetic disease | 0.47 (0.07–3.2) | 0.44 |
Hematol or immunol disease | NA | — |
Hydrocephalus | 4.0 (1.4–11.8) | 0.01 |
Metabolic disease | 3.9 (0.46–33.3) | 0.21 |
Neoplastic disease | NA | — |
Neuromuscular disease | 2.9 (1.1–7.6) | 0.02 |
Renal disease | NA | — |
Respiratory disease | 3.6 (0.47–27.0) | 0.22 |
Scoliosis | 0.57 (0.14–2.2) | 0.42 |
Syringomyelia | 1.5 (0.70–3.1) | 0.30 |
Payer status | ||
Private | Reference | — |
Medicaid | 2.8 (1.1–7.2) | 0.03 |
Other | 1.7 (0.42–6.9) | 0.45 |
Age (yrs) | ||
0–5 | Reference | |
6–12 | 2.9 (0.57–14.6) | 0.20 |
13–18 | 4.6 (0.89–23.4) | 0.07 |
Sex | ||
Male | Reference | — |
Female | 0.59 (0.27–1.3) | 0.18 |
Race | ||
White | Reference | — |
Black | 3.9 (1.3–11.4) | 0.01 |
Hispanic | 3.5 (1.4–8.6) | 0.006 |
Other | 1.8 (0.38–8.1) | 0.47 |